SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

  • This share is currently suspended. It was suspended at a price of 398.00
  • There is currently no data for TYMN

AGM Trading Statement

16 May 2024 07:00

RNS Number : 6169O
Tyman PLC
16 May 2024
 

TYMAN PLC

Annual General Meeting Trading Update

Tyman plc ("Tyman" or the "Group"), a leading international supplier of engineered fenestration components and access solutions to the construction industry, provides an update on trading for the period from 1 January 2024 to 30 April 2024 ("the period"), ahead of the Group's Annual General Meeting being held today at 10.30 a.m. at the offices of Latham & Watkins, 99 Bishopsgate, London, EC2M 3XF.

Current trading

Group revenue for the period decreased by 5% to £205 million on a reported basis, and by 4% on a like-for-like ("LFL") basis. The decrease in LFL revenue reflects, as expected, a continuation of the challenging market conditions experienced throughout 2023, during what is a seasonally less important period.

Tyman's financial performance continues to benefit from a contribution from Lawrence Industries, as well as the impact of previously announced self-help measures. The Group is continuing to progress its strategic initiatives, including activities to grow market share, the roll-out of the new ERP system across North America, and preparation for the consolidation of two sites into one in Owatonna.

Pending transaction with Quanex

The transaction with Quanex announced on 22 April 2024 is currently expected to become effective during the second half of 2024, subject to shareholder approval, regulatory approvals, and other customary conditions to the implementation of the transaction. Additional information on the pending transaction is available on Tyman's website at www.tymanplc.com/investor-relations/recommended-offer-for-tyman-by-quanex.

Rutger Helbing, Chief Executive Officer, commented:

"The Group continues to perform well against a subdued market backdrop and, whilst leading indicators for our major markets continue to signal a challenging near-term market outlook, the Board continues to expect the Group to make progress in 2024.

The structural growth drivers for the Group remain attractive and our market-leading brands and differentiated portfolio of products leave Tyman well placed for the longer term. Our focus remains on taking market share and implementing our self-help measures whilst investing in the business for the future."

16 May 2024

Enquiries

Tyman plc (investor.relations@tymanplc.com, 0207 9768000)

Rutger Helbing - Chief Executive Officer

Jason Ashton - Chief Financial Officer

Matt Jones - Head of Investor Relations

 

MHP (tyman@mhpgroup.com, 07801 894 577)

Reg Hoare / Rachel Farrington

 

Notes to editors

Tyman (TYMN: LSE) is a leading international supplier of engineered fenestration components and access solutions to the construction industry. The company designs and manufactures products that enhance the comfort, sustainability, security, safety and aesthetics of residential homes and commercial buildings. Tyman's portfolio of leading brands serve their markets through three divisions: Tyman North America, Tyman UK and Ireland and Tyman International. Headquartered in London, the Group employs approximately 3,600 people with facilities in 15 countries worldwide. Further information is available at www.tymanplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTAAMFTMTJBBLI
Date   Source Headline
5th Oct 20225:01 pmRNSHolding(s) in Company
5th Oct 20225:00 pmRNSHolding(s) in Company
5th Oct 20224:04 pmRNSHolding(s) in Company
19th Aug 20223:33 pmRNSHolding(s) in Company
1st Aug 20223:34 pmRNSHolding(s) in Company
26th Jul 20227:00 amRNSHalf-year Report
17th Jun 20224:23 pmRNSHolding(s) in Company
6th Jun 20228:08 amRNSDirector/PDMR Shareholding
24th May 20229:57 amRNSDirector/PDMR Shareholding
19th May 20224:41 pmRNSDirector/PDMR Shareholding
19th May 20224:40 pmRNSResult of AGM
19th May 20227:00 amRNSAGM Trading Update
26th Apr 20225:14 pmRNSHolding(s) in Company
25th Apr 20223:36 pmRNSHolding(s) in Company
20th Apr 20223:59 pmRNSDirector/PDMR Shareholding
11th Apr 202211:30 amRNSDirector/PDMR Shareholding
1st Apr 20224:00 pmRNSHolding(s) in Company
1st Apr 20227:00 amRNSNotice of AGM
31st Mar 20229:56 amRNSHolding(s) in Company
31st Mar 20229:51 amRNSHolding(s) in Company
29th Mar 20223:07 pmRNSHolding(s) in Company
29th Mar 202212:00 pmRNSEBT Purchase
29th Mar 202210:54 amRNSHolding(s) in Company
15th Mar 20227:00 amRNSRefinancing of US Private Placement Notes
10th Mar 20223:12 pmRNSDirector/PDMR Shareholding
10th Mar 20222:43 pmRNSHolding(s) in Company
8th Mar 202212:09 pmRNSHolding(s) in Company
3rd Mar 20223:21 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
22nd Feb 20224:10 pmRNSNotice of Results
25th Jan 202210:05 amRNSDirector Declaration
16th Dec 20217:00 amRNSNew Non-Executive Director
25th Nov 202112:57 pmRNSTotal Voting Rights
17th Nov 20217:00 amRNSTrading Update
28th Oct 20219:43 amRNSHolding(s) in Company
14th Sep 20217:49 amRNSHolding(s) in Company
13th Aug 202110:21 amRNSChange of Auditor
30th Jul 20213:28 pmRNSHolding(s) in Company
27th Jul 20217:00 amRNSHalf-year Report
2nd Jun 202112:06 pmRNSHolding(s) in Company
2nd Jun 202112:00 pmRNSHolding(s) in Company
1st Jun 20214:12 pmRNSHolding(s) in Company
1st Jun 20213:53 pmRNSHolding(s) in Company
25th May 20215:30 pmRNSRSA Insurance Group
24th May 20213:22 pmRNSDirector/PDMR Shareholding
20th May 20214:39 pmRNSResult of AGM
20th May 20217:00 amRNSCapital Markets Event
13th May 20214:45 pmRNSHolding(s) in Company
11th May 20214:38 pmRNSHolding(s) in Company
10th May 20214:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.